Teva Pharmaceutical Analysts Recommendations and Consensus

TEVA -- USA Stock  


The current analyst and expert consensus on Teva Pharmaceutical is Hold with 8 hold recommendations. The current projected target price consensus is 45.54 with 13 analysts opinions. One of the most common ways Teva Pharmaceutical analysists use to provide buy or sell recommendation to public are conference calls analysis and financial statements evaluations. Some experts can also talk to Teva Pharmaceutical vendors, executives, and/or customers. Teva Pharmaceutical recommendation module provides expert sentiment on the projected Teva Pharmaceutical target price to derive its highest and lowest estimates based on target price standard deviation of 19.384. Also please take a look at Macroaxis Advice on Teva Pharmaceutical to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

Teva Pharmaceutical Target Price Consensus

Number of Opinions16
Lowered Outlook1
Raized Outlook0
Macroaxis Recommendation   Exposure   Valuation

Teva Pharmaceutical Target Price Projection

Current Price

Teva Pharmaceutical Market Quote

Low Price9.77Odds
High Price9.98Odds


Target Price

Analyst Consensus On Target Price

Low Estimate27.0Odds
High Estimate100.0Odds
Number of Analysts13
Standard Deviation19.384


Teva Pharmaceutical Analysit Ratings

Average Consensus